Skip to main content
Figure 2 | Cardiovascular Diabetology

Figure 2

From: Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study

Figure 2

Incidence MS and DM (%) according to baseline fasting insulin quartile in the whole cohort without any MS component at baseline. Cut off points for the quartiles (IU/mL) were I: fasting insulin≤6.01, II: 6.02≤ fasting insulin ≤ 7.29, III: 7.30≤fasting insulin≤8.97, IV: fasting insulin≥8.98. MS, Metabolic syndrome; DM, diabetes mellitus.

Back to article page